Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

GENETICS

Introducing routine genetic testing for patients with CKD

Nature Reviews Nephrology volume 15, pages 321–322 (2019)Cite this article

Subjects

Chronic kidney disease (CKD) is often clinically silent and traditional clinical data alone cannot differentiate disease subtypes. A recent study of the genetic basis of CKD in adults that examined the prevalence of monogenic kidney disease aetiologies supports the use of genetic analysis to improve diagnostics and treatment in CKD.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Genetic contribution to CKD.

References

  1. Webster, A. C. et al. Chronic kidney disease. Lancet 389, 1238–1252 (2017).

    Article  Google Scholar 

  2. Groopman, E. E. et al. Diagnostic utility of exome sequencing for kidney disease. N. Engl. J. Med. 380, 142–151 (2019).

    Article  CAS  Google Scholar 

  3. Freedman, B. I. et al. Population-based screening for family history of end-stage renal disease among incident dialysis patients. Am. J. Nephrol. 25, 529–535 (2005).

    Article  Google Scholar 

  4. Vivante, A. & Hildebrandt, F. Exploring the genetic basis of early-onset chronic kidney disease. Nat. Rev. Nephrol. 12, 133–146 (2016).

    Article  CAS  Google Scholar 

  5. Groopman, E. E., Rasouly, H. M. & Gharavi, A. G. Genomic medicine for kidney disease. Nat. Rev. Nephrol. 14, 83–104 (2018).

    Article  CAS  Google Scholar 

  6. Genovese, G. et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329, 841–845 (2010).

    Article  CAS  Google Scholar 

  7. Tzur, S. et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum. Genet. 128, 345–350 (2010).

    Article  CAS  Google Scholar 

  8. Stanescu, H. C. et al. Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N. Engl. J. Med. 364, 616–626 (2011).

    Article  CAS  Google Scholar 

  9. Kalatharan, V., Lemaire, M. & Lanktree, M. B. Opportunities and challenges for genetic studies of end-stage renal disease in Canada. Can. J. Kidney Health Dis. 5, 2054358118789368 (2018).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Department B and Pediatric Nephrology Unit, Edmond and Lily Safra Children’s Hospital, Chaim Sheba Medical Center, Tel Hashomer and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    Asaf Vivante

  2. Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel

    Karl Skorecki

Authors
  1. Asaf Vivante
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karl Skorecki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Asaf Vivante or Karl Skorecki.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vivante, A., Skorecki, K. Introducing routine genetic testing for patients with CKD. Nat Rev Nephrol 15, 321–322 (2019). https://doi.org/10.1038/s41581-019-0140-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41581-019-0140-9

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing